Adamis Pharmaceuticals Submits Fast Track Application to : v

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the submission of a Fast Track Application...

Related Keywords

New York , United States , Shyam Kottilil , Robert Uhl , Dennisj Carlo , Company Tempol , Company Phase , Linkedin , Twitter , Adamis Pharmaceuticals Corporation , National Institutes Of Health , Institute Of Human Virology , Drug Administration , Adamis Pharmaceuticals , Adamis Pharmaceuticals Corporation Nasdaq , Us Compounding Inc , University Of Maryland School Medicine , Stanford University , Division Of Clinical Care , Pharmaceuticals Corporation , Fast Track Application , Maryland School , Clinical Care , Human Virology , Principal Investigator , Chief Executive Officer , Fast Track , Because Tempol , National Institutes , Private Securities Litigation Reform Act , Southern District , Nasdaq Admp , Admp , Jempol , Antiviral , Covid 19 ,